Cargando…
Acute PDE4 Inhibition Induces a Transient Increase in Blood Glucose in Mice
cAMP-phosphodiesterase 4 (PDE4) inhibitors are currently approved for the treatment of inflammatory diseases. There is interest in expanding the therapeutic application of PDE4 inhibitors to metabolic disorders, as their chronic application induces weight loss in patients and animals and improves gl...
Autores principales: | Irelan, Daniel, Boyd, Abigail, Fiedler, Edward, Lochmaier, Peter, McDonough, Will, Aragon, Ileana V., Rachek, Lyudmila, Abou Saleh, Lina, Richter, Wito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963939/ https://www.ncbi.nlm.nih.gov/pubmed/36834669 http://dx.doi.org/10.3390/ijms24043260 |
Ejemplares similares
-
Non-Selective PDE4 Inhibition Induces a Rapid and Transient Decrease of Serum Potassium in Mice
por: Boyd, Abigail, et al.
Publicado: (2022) -
Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice
por: Boyd, Abigail, et al.
Publicado: (2021) -
PDE4D and PDE4B Function in Distinct Subcellular Compartments in Mouse Embryonic Fibroblasts
por: Blackman, Brigitte E., et al.
Publicado: (2011) -
Conserved expression and functions of PDE4 in rodent and human heart
por: Richter, Wito, et al.
Publicado: (2010) -
Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
por: Xin, Wenkuan, et al.
Publicado: (2008)